NO154495C - Analogifremgangsmaate for fremstilling av en benzopyranforbindelse. - Google Patents

Analogifremgangsmaate for fremstilling av en benzopyranforbindelse.

Info

Publication number
NO154495C
NO154495C NO812042A NO812042A NO154495C NO 154495 C NO154495 C NO 154495C NO 812042 A NO812042 A NO 812042A NO 812042 A NO812042 A NO 812042A NO 154495 C NO154495 C NO 154495C
Authority
NO
Norway
Prior art keywords
preparing
benzopyran compound
analogy procedure
analogy
procedure
Prior art date
Application number
NO812042A
Other languages
English (en)
Other versions
NO154495B (no
NO812042L (no
Inventor
Masami Shiratsuchi
Noboru Shimizu
Yoshinori Kyotani
Hisashi Kunieda
Seiichi Sato
Toshihiro Akashi
Hiromichi Shigyo
Kiyoshi Kawamura
Masaniko Nagakura
Naotoshi Sawada
Yasumi Uchida
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP8084180A external-priority patent/JPS6054317B2/ja
Priority claimed from JP55182854A external-priority patent/JPS57106619A/ja
Application filed by Kowa Co filed Critical Kowa Co
Publication of NO812042L publication Critical patent/NO812042L/no
Publication of NO154495B publication Critical patent/NO154495B/no
Publication of NO154495C publication Critical patent/NO154495C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO812042A 1980-06-17 1981-06-16 Analogifremgangsmaate for fremstilling av en benzopyranforbindelse. NO154495C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8084180A JPS6054317B2 (ja) 1980-06-17 1980-06-17 新規ベンゾピラン誘導体
JP55182854A JPS57106619A (en) 1980-12-25 1980-12-25 Remedy for circulatory disease

Publications (3)

Publication Number Publication Date
NO812042L NO812042L (no) 1981-12-18
NO154495B NO154495B (no) 1986-06-23
NO154495C true NO154495C (no) 1986-10-01

Family

ID=26421809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812042A NO154495C (no) 1980-06-17 1981-06-16 Analogifremgangsmaate for fremstilling av en benzopyranforbindelse.

Country Status (16)

Country Link
US (1) US4394382A (no)
EP (1) EP0042299B1 (no)
KR (1) KR850000193B1 (no)
AU (1) AU543347B2 (no)
CA (1) CA1178598A (no)
CS (1) CS226731B2 (no)
DD (1) DD160453A5 (no)
DE (1) DE3166300D1 (no)
DK (1) DK154557C (no)
ES (1) ES8300104A1 (no)
FI (1) FI79307C (no)
IE (1) IE52067B1 (no)
NO (1) NO154495C (no)
PL (1) PL130537B1 (no)
SU (1) SU1212325A3 (no)
ZA (1) ZA814042B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5965076A (ja) * 1982-10-05 1984-04-13 Kowa Co 新規なキノリン誘導体
JPS60181083A (ja) * 1984-02-29 1985-09-14 Kowa Co 新規ラセミ体及びその変換方法
JPS60208973A (ja) * 1984-03-31 1985-10-21 Kowa Co 循環系疾患治療剤
GB8730051D0 (en) * 1987-12-23 1988-02-03 Beecham Group Plc Novel compounds
ATE244708T1 (de) * 1996-05-14 2003-07-15 Glaxo Group Ltd Benzofurane und benzpyrane als chronobiologische mittel
TWI290470B (en) 1999-12-01 2007-12-01 Sankyo Co The composition for treating glaucoma
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
AU2003275609A1 (en) * 2002-10-24 2004-05-13 Kowa Co., Ltd. Nerve fiber regeneration accelerator
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
TWI646091B (zh) * 2012-12-28 2019-01-01 日商衛斯克慧特股份有限公司 鹽類及晶形
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1493998A (en) * 1975-06-03 1977-12-07 Beecham Group Ltd Propanolamine derivatives
JPS54106476A (en) * 1978-01-04 1979-08-21 Merck & Co Inc Multiisubstituted 22*33lower alkylaminoo22 r100propoxy*pyridine
DE2804625A1 (de) * 1978-02-03 1979-08-09 Thomae Gmbh Dr K Neue 4-acylamino-phenyl-aethanolamine
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DD160453A5 (de) 1983-08-03
FI79307B (fi) 1989-08-31
AU7165281A (en) 1981-12-24
ES503091A0 (es) 1982-10-01
EP0042299B1 (en) 1984-09-26
FI811856L (fi) 1981-12-18
AU543347B2 (en) 1985-04-18
CA1178598A (en) 1984-11-27
ZA814042B (en) 1982-06-30
IE52067B1 (en) 1987-06-10
CS226731B2 (en) 1984-04-16
DE3166300D1 (en) 1984-10-31
SU1212325A3 (ru) 1986-02-15
KR850000193B1 (ko) 1985-03-05
EP0042299A1 (en) 1981-12-23
NO154495B (no) 1986-06-23
US4394382A (en) 1983-07-19
DK154557C (da) 1989-04-17
NO812042L (no) 1981-12-18
DK264181A (da) 1981-12-18
KR830006268A (ko) 1983-09-20
ES8300104A1 (es) 1982-10-01
PL130537B1 (en) 1984-08-31
PL231734A1 (no) 1982-08-16
IE811312L (en) 1981-12-17
DK154557B (da) 1988-11-28
FI79307C (fi) 1989-12-11

Similar Documents

Publication Publication Date Title
ES507198A0 (es) Procedimiento de preparar compuesto carbostiribicos.
NO157369C (no) Fremgangsmaate for fremstilling av en dipyridamol-retardform.
NO159061C (no) Fremgangsmaate for fremstilling av en bromhexin-retardform.
ES507493A0 (es) Procedimiento de preparar compuestos benzoheterociclicos.
NO152964C (no) Fremgangsmaate for fremstilling av mikrokapsler.
DK247081A (da) Fremgansmaade til fremstilling af derivater af forbindelse ml-236b.
NO812358L (no) Fremgangsmaate for modifisering av karbohydrater.
NO813208L (no) Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.
NO158993C (no) Fremgangsmaate ved fremstilling av en gel.
NO811811L (no) Fremgangsmaate for fremstilling av papir.
DK362781A (da) Fremgangsmaade til fremstilling af en kapsel
DK159390C (da) Analogifremgangsmaade til fremstilling af 3-(1-piperidinylalkyl)-4h-pyridooe1,2-aaapyrimidin-4-on-derivater
NO154495C (no) Analogifremgangsmaate for fremstilling av en benzopyranforbindelse.
ES507545A0 (es) Procedimiento de preparar compuestos carbostirilicos.
NO154882C (no) Fremgangsmaate for fremstilling av 2-(2-(1,4-benzodioksanyl)) -2-imidazolin.
NO813442L (no) Fremgangsmaate for fremstilling av 2-guanidin-4-heteroaryltiazolderivater
ES516133A0 (es) Un procedimiento de preparacion de un compuesto.
NO152894C (no) Fremgangsmaate ved fremstilling av ureapellets.
NO158061C (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-metyl-n-2-pyridyl-2h-1,2-benzotiazin-3-karboksamid-1,1-dioksyd (piroxicam).
DK161310C (da) Analogifremgangsmaade til fremstilling af aminopropoxyphenylderivater
DK159681A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa-(polyfluoralkyl)-1h-pyrrol-2-methanaminer
NO812841L (no) Fremgangsmaate til fremstilling av florerte pentendiaminderivater
NO153877C (no) Fremgangsmaate ved fremstilling av en ski.
DK152674C (da) Analogifremgangsmaade til fremstilling af 3-metyltiometyl-4-oxo-quinolonderivater
DK146067C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-5-phenoxypropoxypyrimidiner

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JUNE 2001